CLINICAL AND LABORATORY CHARACTERISTICS IN PATIENTS WITH EPSTEIN-BARR VIRUS INFECTION IMAGES IN BONE MARROW HISTOPATHOLOGY

An Do Thi Vinh1, , Tung Nguyen Tuan1, Hieu Nguyen Trung1, Hoa Ngo Thi1, Truong Vu Van1
1 Trung tâm Huyết học và Truyền máu, Bệnh viện Bạch Mai

Author contact

Main Article Content

Abstract

Objective: To describe the clinical and laboratory characteristics in patients exhibiting EBV infection in bone marrow histopathology. Participants and Methods: We conducted a retrospective study on 1987 cases with bone marrow biopsy (January 2022 - April 2023) at Bach Mai Hospital. Results: The bone marrow biopsy showed a total of 82 cases had phagocytosis images suggestive of EBV and detected 69 cases of EBV positive by PCR technique (polymerase chain reaction). EBVpositive patients in addition to having changes in hematological parameters such as a decrease in 1, 2 or 3 lines of peripheral blood cells, other clinical signs such as fever, infection, and lung damage are also recorded. receive. The rate of detection of EBV-positive cells in the bone marrow appears to be slightly higher in immunocompromised individuals (4.5%) than in immunocompetent patients (1.3%). Conclusion: Although phagocytic images in bone marrow biopsies may appear in various disease contexts, certain morphological features can suggest the presence of EBV. Therefore, special attention should be paid during the examination process to assist clinicians in accurately diagnosing EBV infection cases.

Article Details

References

1. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol. 2007;38(9):1293-1304.
2. Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood. 2006;107(3):862-869.
3. Groux H, Cottrez F, Montpellier C, et al. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood. 1997;89(12):4521-4530.
4. Rezk SA, Zhao X, Weiss LM. Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update. Hum Pathol. 2018;79:18-41.
5. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9(3):395-404.
6. Ouedraogo DE, Makinson A, Kuster N, et al. Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy. Blood. 2013;122(19):3413-3416.
7. Chung HJ, Chi HS, Cho YU, et al. Bone marrow fibrin-ring granuloma: review of 24 cases. Ann Lab Med. 2007;27(3):182-187.
8. Farrell D, Mott SL, Zhao X, Reyes RA, Goyal B. Epstein-Barr virus incidental expression in bone marrow cells: a study of 230 consecutive bone marrow biopsy samples. Hum Pathol. 2019;88:60-65.
9. Marques H, Eleutério J Jr, Penha-Filho ML, et al. Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin’s lymphoma is not associated with prognosis. Oncol Lett. 2012;4(6):1285-1289.
10. Saleem A, Johnson R, Lei L, Lezema L. Novel IRF8 and PD-L1 molecular aberrations in systemic EBV-positive T-cell lymphoma of childhood. Hum Pathol. 2020;106:93-98.